January 2nd, 2013
CABG Highly Cost-Effective in Diabetics with Multivessel Disease
Larry Husten, PHD
In November the main results of the FREEDOM trial showed that diabetics with multivessel disease do better with CABG than PCI. Now the findings of the trial’s cost-effectiveness study, published online in Circulation, demonstrate that CABG is also highly cost-effective when compared with PCI. Elizabeth Magnuson and colleagues found that although CABG initially cost nearly $9000 more than PCI ($34,467 […]
NEJM Journal Watch — Recent Cardiology Articles- 10-Year Mortality in Patients Undergoing PCI for First-Time ST-Segment Elevation Myocardial Infarction
- Possible Connection Between Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
- Does Knowledge of Asymptomatic Coronary Ischemia Improve Outcomes After Major Vascular Surgery?
- Effect of Telecardiology After Hospital Discharge for Acute Coronary Syndromes
- Intensive BP Reduction for Preventing Major Adverse Cardiovascular Events